Symbols / ZVSA $0.18 -11.15% ZyVersa Therapeutics, Inc.

Healthcare • Biotechnology • United States • OQB
ZVSA Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Stephen C. Glover
Exch · Country OQB · United States
Market Cap 1.46M
Enterprise Value 2.36M
Income -24.49M
Sales
FCF (ttm)
Book/sh -1.45
Cash/sh 0.04
Employees 6
Insider 10d
IPO Feb 11, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -0.04
PEG
P/S
P/B -0.12
P/C
EV/EBITDA
EV/Sales
Quick Ratio 0.02
Current Ratio 0.05
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y -4.80
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-08-13
Earnings (prior) 2024-11-14
ROA -34.55%
ROE
ROIC
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand
Shs Float 7.68M
Insider Own 0.02%
Instit Own 5.15%
Short Float 7.38%
Short Ratio 0.25
Short Interest 359.25K
52W High 1.67
vs 52W High -89.22%
52W Low 0.11
vs 52W Low 63.73%
Beta
Impl. Vol.
Rel Volume 0.19
Avg Volume 16.00K
Volume 3.06K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.20
Price $0.18
Change -11.15%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
6.84
-25.09%
9.14
-36.64%
14.42
+10.82%
13.01
Research And Development
1.11
-37.44%
1.78
-44.53%
3.21
-40.69%
5.41
Selling General And Administration
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
General And Administrative Expense
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
Other Gand A
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
Total Expenses
6.84
-25.09%
9.14
-36.64%
14.42
+10.82%
13.01
Operating Income
-6.84
+25.09%
-9.14
+36.64%
-14.42
-10.82%
-13.01
Total Operating Income As Reported
-25.49
-179.01%
-9.14
+91.52%
-107.75
-728.05%
-13.01
EBITDA
-25.29
-177.01%
-9.13
+36.64%
-14.41
-5.88%
-13.61
Normalized EBITDA
-6.64
+27.24%
-9.13
-111.57%
78.92
+706.95%
-13.00
Reconciled Depreciation
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
EBIT
-25.29
-176.80%
-9.14
+36.64%
-14.42
-5.88%
-13.62
Total Unusual Items
-18.65
0.00
+100.00%
-93.33
-15276.16%
-0.61
Total Unusual Items Excluding Goodwill
-18.65
0.00
+100.00%
-93.33
-15276.16%
-0.61
Special Income Charges
-18.65
0.00
+100.00%
-93.33
0.00
Other Special Charges
Impairment Of Capital Assets
0.00
-100.00%
11.90
0.00
Write Off
18.65
0.00
-100.00%
81.44
0.00
Net Income
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Pretax Income
-25.80
-174.32%
-9.41
+91.27%
-107.75
-667.06%
-14.05
Net Non Operating Interest Income Expense
-0.51
-90.18%
-0.27
-59149.45%
0.00
+100.11%
-0.43
Interest Expense Non Operating
0.51
+90.18%
0.27
0.43
Net Interest Income
-0.51
-90.18%
-0.27
-59149.45%
0.00
+100.11%
-0.43
Interest Expense
0.51
+90.18%
0.27
0.43
Interest Income Non Operating
0.00
Interest Income
0.00
Other Income Expense
-18.45
-93.33
-15276.16%
-0.61
Other Non Operating Income Expenses
0.20
Gain On Sale Of Security
-0.61
Tax Provision
-0.85
-12726.52%
0.01
+100.07%
-9.46
0.00
Tax Rate For Calcs
0.00
-84.29%
0.00
+139.31%
0.00
0.00
Tax Effect Of Unusual Items
-0.62
0.00
+100.00%
-8.19
0.00
Net Income Including Noncontrolling Interests
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income From Continuing Operation Net Minority Interest
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income From Continuing And Discontinued Operation
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income Continuous Operations
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Normalized Income
-6.92
+26.49%
-9.41
+28.44%
-13.15
+2.13%
-13.44
Net Income Common Stockholders
-24.95
-165.07%
-9.41
+91.14%
-106.25
-341.53%
-24.06
Diluted EPS
-8.48
+99.22%
-1,089.70
-214.49%
-346.50
Basic EPS
-8.48
+99.22%
-1,089.70
-214.49%
-346.50
Basic Average Shares
1.11
+1038.50%
0.10
+41.05%
0.07
Diluted Average Shares
1.11
+1038.50%
0.10
+41.05%
0.07
Diluted NI Availto Com Stockholders
-24.95
-165.07%
-9.41
+91.14%
-106.25
-341.53%
-24.06
Preferred Stock Dividends
7.95
-20.64%
10.02
Total Other Finance Cost
0.27
+59149.45%
-0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
0.35
-98.31%
20.60
-6.85%
22.11
Current Assets
0.35
-79.72%
1.72
-48.83%
3.35
Cash Cash Equivalents And Short Term Investments
0.10
-93.35%
1.53
-51.21%
3.14
Cash And Cash Equivalents
0.10
-93.35%
1.53
-51.21%
3.14
Cash Financial
0.10
-93.35%
1.53
-51.21%
3.14
Prepaid Assets
0.01
0.00
0.00
Other Current Assets
0.23
+25.30%
0.18
-14.20%
0.22
Total Non Current Assets
0.00
-100.00%
18.88
+0.65%
18.76
Net PPE
0.00
-100.00%
0.01
Gross PPE
0.05
-13.10%
0.06
Accumulated Depreciation
-0.05
-15.38%
-0.05
Other Properties
0.05
-13.10%
0.06
Goodwill And Other Intangible Assets
0.00
-100.00%
18.65
+0.00%
18.65
Goodwill
0.00
Other Intangible Assets
18.65
+0.00%
18.65
Non Current Deferred Assets
0.00
-100.00%
0.06
0.00
Non Current Prepaid Assets
0.00
-100.00%
0.18
+81.24%
0.10
Total Liabilities Net Minority Interest
12.73
+5.39%
12.08
+9.45%
11.04
Current Liabilities
12.73
+13.39%
11.23
+10.17%
10.19
Payables And Accrued Expenses
12.73
+13.39%
11.22
+15.96%
9.68
Payables
10.12
+8.42%
9.34
+10.74%
8.43
Accounts Payable
10.12
+8.42%
9.34
+10.74%
8.43
Current Accrued Expenses
2.60
+38.01%
1.89
+51.27%
1.25
Total Tax Payable
0.00
Income Tax Payable
0.00
Current Debt And Capital Lease Obligation
0.01
Current Debt
Other Current Borrowings
Current Capital Lease Obligation
0.00
-100.00%
0.01
Current Deferred Liabilities
Other Current Liabilities
0.01
+0.00%
0.01
-98.57%
0.51
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.85
+0.80%
0.84
Non Current Deferred Liabilities
0.00
-100.00%
0.85
+0.80%
0.84
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.85
+0.80%
0.84
Stockholders Equity
-12.39
-245.45%
8.52
-23.10%
11.07
Common Stock Equity
-12.39
-245.45%
8.52
-23.10%
11.07
Capital Stock
0.00
+221.43%
0.00
+514.63%
0.00
Common Stock
0.00
+222.31%
0.00
+527.50%
0.00
Preferred Stock
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
8.10
+222.78%
2.51
+518.99%
0.41
Ordinary Shares Number
8.10
+222.78%
2.51
+518.99%
0.41
Treasury Shares Number
0.00
+0.00%
0.00
+16.67%
0.00
Additional Paid In Capital
125.20
+3.34%
121.16
+6.00%
114.30
Retained Earnings
-137.58
-22.15%
-112.63
-9.12%
-103.22
Treasury Stock
0.01
+0.00%
0.01
+0.00%
0.01
Total Equity Gross Minority Interest
-12.39
-245.45%
8.52
-23.10%
11.07
Total Capitalization
-12.39
-245.45%
8.52
-23.10%
11.07
Working Capital
-12.39
-30.17%
-9.52
-39.08%
-6.84
Invested Capital
-12.39
-245.45%
8.52
-23.10%
11.07
Total Debt
0.00
-100.00%
0.01
Net Debt
Capital Lease Obligations
0.00
-100.00%
0.01
Net Tangible Assets
-12.39
-22.26%
-10.13
-33.78%
-7.57
Tangible Book Value
-12.39
-22.26%
-10.13
-33.78%
-7.57
Interest Payable
0.67
+147.97%
0.27
Other Equity Interest
Preferred Stock Equity
0.00
+0.00%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Cash Flow From Continuing Operating Activities
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Net Income From Continuing Operations
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Depreciation Amortization Depletion
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Depreciation
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Depreciation And Amortization
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Other Non Cash Items
0.24
+17.30%
0.20
-89.34%
1.92
+1507.01%
0.12
Stock Based Compensation
0.22
-68.42%
0.71
-40.86%
1.19
-66.16%
3.52
Asset Impairment Charge
18.71
0.00
-100.00%
93.33
0.00
Deferred Tax
-0.85
-12726.52%
0.01
+100.07%
-9.48
0.00
Deferred Income Tax
-0.85
-12726.52%
0.01
+100.07%
-9.48
0.00
Operating Gains Losses
0.61
Gain Loss On Investment Securities
0.61
Gain Loss On Sale Of PPE
Change In Working Capital
1.52
+56.87%
0.97
-62.70%
2.60
-68.64%
8.29
Change In Prepaid Assets
0.12
+333.05%
-0.05
-125.59%
0.19
-41.37%
0.33
Change In Payables And Accrued Expense
1.41
+36.81%
1.03
-59.00%
2.51
-68.85%
8.05
Change In Accrued Expense
0.72
+414.13%
0.14
+37.40%
0.10
-92.91%
1.43
Change In Payable
0.69
-22.43%
0.89
-63.07%
2.41
-63.64%
6.62
Change In Account Payable
0.69
-22.43%
0.89
-63.07%
2.41
-63.64%
6.62
Change In Other Working Capital
0.10
Change In Other Current Liabilities
0.00
+100.00%
-0.01
+91.35%
-0.10
-16.26%
-0.09
Financing Cash Flow
3.69
-37.67%
5.91
-0.73%
5.96
+219.31%
1.87
Cash Flow From Continuing Financing Activities
3.69
-37.67%
5.91
-0.73%
5.96
+219.31%
1.87
Net Issuance Payments Of Debt
0.00
Issuance Of Debt
0.00
Long Term Debt Issuance
Net Long Term Debt Issuance
Short Term Debt Issuance
0.00
Net Short Term Debt Issuance
0.00
Net Common Stock Issuance
0.00
-100.00%
1.35
-92.52%
18.11
0.00
Common Stock Payments
0.00
+100.00%
-0.01
0.00
Repurchase Of Capital Stock
0.00
+100.00%
-10.70
0.00
Proceeds From Stock Option Exercised
4.05
-21.88%
5.19
+436.10%
0.97
0.00
Net Other Financing Charges
-0.37
+41.64%
-0.63
+74.07%
-2.42
-2343.61%
-0.10
Changes In Cash
-1.43
+11.05%
-1.61
+41.88%
-2.76
-845.67%
0.37
Beginning Cash Position
1.53
-51.21%
3.14
-46.84%
5.90
+1696.27%
0.33
End Cash Position
0.10
-93.35%
1.53
-51.21%
3.14
+348.67%
0.70
Free Cash Flow
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Interest Paid Supplemental Data
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
Common Stock Issuance
0.00
-100.00%
1.35
-92.52%
18.11
0.00
Issuance Of Capital Stock
0.00
-100.00%
1.35
-92.52%
18.11
+822.07%
1.96
Net Preferred Stock Issuance
0.00
+100.00%
-10.70
-644.44%
1.96
Preferred Stock Issuance
0.00
-100.00%
1.96
Preferred Stock Payments
0.00
+100.00%
-10.70
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category